The prescription of maintenance treatment for opioid dependence has increased dramatically in France since the approval of high-dose buprenorphine in general practice. Community pharmacists are particularly involved since daily dispensing is recommended. A postal survey was conducted within a representative network of community pharmacies in Aquitaine, south-western France. The objective was to assess quantitative and qualitative data on these treatments in the region through pharmacists' opinions and experiences. Out of 61 responders, 62 per cent had already dispensed maintenance treatment. During the survey, 88 patients were under treatment at these pharmacies. Nearly 80 per cent of the pharmacists agreed with the dispensing of these treatments and more than 60 per cent had a positive opinion of them. Community pharmacists feel concerned by the treatment for opioid dependence.